Niagen Bioscience (NAGE) Other Non Operating Income (2016 - 2018)
Niagen Bioscience's (NAGE) quarterly Other Non Operating Income came in at -$65000.0 in Q2 2018, up 79.24% on a QoQ basis from -$313099.0 in Q3 2016.
Niagen Bioscience (NAGE) Other Non Operating Income (2016 - 2018) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Other Non Operating Income data on file, last reported at -$65000.0 in Q2 2018.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$65000.0 in Q2 2018; TTM through Dec 2018 was -$65000.0, a N/A change from a year earlier, with the FY2018 full-year figure at -$65000.0, changed N/A from the prior year.
- Other Non Operating Income for Q2 2018 stood at -$65000.0, up from -$313099.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for NAGE reached as high as -$65000.0 in Q2 2018 and fell as low as -$313099.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Niagen Bioscience | 260.13 Mn | 193.58 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -65,000.00 |
| Jul 2, 2016 | -313,099.00 |